Panobinostat monotherapy and combination therapy in patients with acute myeloid leukemia: Results from two clinical trials

Richard F. Schlenk, Jürgen Krauter, Emmanuel Raffoux, Karl Anton Kreuzer, Markus Schaich, Lucien Noens, Thomas Pabst, Madhuri Vusirikala, Didier Bouscary, Andrew Spencer, Anna Candoni, Jorgesierra Gil, Noah Berkowitz, Hans Jochen Weber, Oliver Ottmann

Research output: Contribution to journalLetter

6 Scopus citations
Original languageEnglish (US)
Pages (from-to)E25-E28
JournalHaematologica
Volume103
Issue number1
DOIs
StatePublished - Jan 2018

ASJC Scopus subject areas

  • Hematology

Cite this

Schlenk, R. F., Krauter, J., Raffoux, E., Kreuzer, K. A., Schaich, M., Noens, L., Pabst, T., Vusirikala, M., Bouscary, D., Spencer, A., Candoni, A., Gil, J., Berkowitz, N., Weber, H. J., & Ottmann, O. (2018). Panobinostat monotherapy and combination therapy in patients with acute myeloid leukemia: Results from two clinical trials. Haematologica, 103(1), E25-E28. https://doi.org/10.3324/haematol.2017.172411